Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DGX

Here's What to Expect From Quest Diagnostics’ Next Earnings Report

Quest Diagnostics is expected to release its Q1 results this month, and analysts expect a single-digit surge in earnings.

Mini desktop supercomputer coming this year — powerful enough to run advanced AI models and small enough to fit in your bag

Mini desktop supercomputer coming this year — powerful enough to run advanced AI models and small enough to fit in your bag

The new DGX machines are portable but powerful enough to drive complex AI modules and research, with processing capabilities previously only available in data centers.

Is Quest Diagnostics Stock Outperforming the S&P 500?

Is Quest Diagnostics Stock Outperforming the S&P 500?

Although Quest Diagnostics has outperformed the S&P 500 Index over the past year, analysts are cautiously optimistic about the stock’s prospects.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Are Wall Street Analysts Bullish on Quest Diagnostics Stock?

Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Earnings Preview: What to Expect From Quest Diagnostics' Report

Quest Diagnostics will release its fourth-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks?

Despite Quest Diagnostics' outperformance relative to its industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock?

Despite Quest Diagnostics’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

inkl

Read news from The Economist, FT, and more,
with one subscription

Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know

Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know

With Quest Diagnostics gearing up to release its third-quarter earnings later this month, analysts expect a low single-digit earnings growth.

Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector recently, and analysts are bullish about the stock's future.

Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Quest Diagnostics’ Q2 2024 Earnings: What to Expect

Quest Diagnostics’ Q2 2024 Earnings: What to Expect

As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Nvidia Unveils DGX GH200 Supercomputer, Grace Hopper Superchips in Production

Nvidia Unveils DGX GH200 Supercomputer, Grace Hopper Superchips in Production

Nvidia announced that its Grace Hopper CPU+GPU Superchips are now in production, and also introduced the DGX GH200 supercomputer and MGX platforms that will use its new AI-optimized Ethernet Spectrum-X networking platform.

Tom’s Hardware

2 Monkeypox Stocks to Watch This Week

2 Monkeypox Stocks to Watch This Week

Increasing cases of monkeypox worldwide have led the WHO to declare it a global emergency. With the infection spread in more than 85 countries and governments rushing to curb the spread, vaccine manufacturers are poised to benefit significantly. Thus, we think monkeypox stocks Quest Diagnostics (DGX) and SIGA Technologies (SIGA)…

Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance

Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance

Quest Diagnostics Inc (NYSE:DGX) posted a better-than-expected Q1 FY22 adjusted EPS of $3.22, down 14.4% Y/Y, beating the consensus of $2.97. Sales came in at $2.61 billion, a decline of 4% Y/Y, slightly lower than the Wall Street estimate of $2.63 billion. COVID-19 testing revenues fell 27.6% to $599 million, while Base…

Get all your
news in one place.

100’s of premium titles.
One news app.

Quest Diagnostics Secures CDC Contract To Support COVID-19 Research

The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis. Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…

This Foreboding Sign Looms Over Quest Diagnostics's Chart

If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Take Advantage of the Dip and Buy These 4 Beaten-Down Healthcare Stocks

The healthcare industry is expected to achieve solid growth with rising investments in the sector and soaring demand from an aging population. Therefore, we think it could be wise to bet on beaten-down healthcare stocks West Pharmaceutical (WST), Bio-Rad Laboratories (BIO), Quest Diagnostics (DGX), and Masimo Corporation (MASI), which possess…

What 8 Analyst Ratings Have To Say About Quest Diagnostics

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services

Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected

Where Quest Diagnostics Stands With Analysts

Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings:

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Centers for Disease Control and Prevention

Quest Diagnostics

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

264,572 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play